Medical / Pharmaceuticals News and Press Releases

Medical / Pharmaceuticals

Releases published in the last 30 days.

Page 1 of 2

Reshaping bone repair with 3D printing: 5/14/2025 5:12:49 AM; What if surgeons could replace damaged bone with a solution tailor-made to each patient? That’s the question researchers at the University of Waterloo are seeking to answer as they develop a material that mimics the behaviour of human bone and is capable of being 3D printed with a high degree of accuracy. Identifying a solution Lead researcher Dr.
Study shows vision-language models can’t handle queries with negation words: 5/14/2025 3:06:05 AM; Imagine a radiologist examining a chest X-ray from a new patient. She notices the patient has swelling in the tissue but does not have an enlarged heart.
Do bevacizumab’s ovarian cancer clinical trial results hold up in the real world?: 5/13/2025 5:14:27 PM; A real-world study based on information from an electronic health records–derived database reveals limited benefits of adding bevacizumab to first-line chemotherapy for patients with ovarian cancer, consistent with previous clinical trials.
New Study Reveals Our Skin’s Own Bacteria Can Help Protect Us From the Bad Effects of Sunlight: 5/13/2025 5:06:11 PM; The skin microbiome plays an important role in health and disease. Researchers have now substantiated that certain skin bacteria can protect us from the sun’s ultraviolet (UV) radiation specifically by metabolizing cis -urocanic acid using an enzyme called urocanase.
AMA names Dr. John Whyte next CEO/EVP: 5/12/2025 8:43:26 AM; CHICAGO – The American Medical Association (AMA) named John J. Whyte, M.D., M.P.H., as its next chief executive officer and executive vice president.
Intertek Expands Pharmaceutical Services Laboratory to Enhance Capabilities in Inhaled Biologics and Accelerate Drug Development: 5/9/2025 10:07:32 AM; Intertek, a leading Total Quality Assurance provider to industries worldwide, is expanding its Good Manufacturing Practice (GMP) pharmaceutical services laboratory in Melbourn, near Cambridge, UK.
Calquence plus chemoimmunotherapy approved in the EU as first and only BTK inhibitor for 1st-line mantle cell lymphoma: 5/8/2025 12:32:16 PM; AstraZeneca’s Calquence (acalabrutinib) in combination with bendamustine and rituximab has been approved in the European Union (EU) for the treatment of adult patients with previously untreated mantle cell lymphoma (MCL) who are not eligible for autologous stem cell transplant.
Birdeye unveils the AI Vision for Hyperlocal Marketing: 5/8/2025 8:00:00 AM; Traditional SaaS models are no longer enough. Brands don’t need more tools—they need results. Today, Birdeye, the leader in Hyperlocal Marketing, announces its boldest innovation yet: a reimagined AI architecture that powers a Service as a Software model - delivering business outcomes directly through autonomous and supervised AI agents and multi-layered LLMs.
Pharma Partnering EU Summit 2025 to Unite European Pharma Innovators in Brussels: 5/8/2025 5:56:28 AM; The Pharma Partnering EU Summit 2025 is scheduled for May 22–23 in Brussels, offering a premier platform for pharmaceutical professionals to network, learn, and collaborate.
Pharma Partnering US Summit 2025 to Convene Industry Leaders in San Diego: 5/8/2025 5:48:37 AM; The Pharma Partnering US Summit 2025 is set to take place on May 14–15 at the San Diego Marriott Del Mar, bringing together senior executives and professionals from the pharmaceutical and biotech industries.
AdvaMed, U.K. Medtech Association Call for Flexibility on Tariffs, “Regulatory Convergence”: 5/7/2025 10:42:44 AM; AdvaMed, the Medtech Association, the world’s largest organization representing medtech innovators, and the Association of British HealthTech Industries (ABHI), the leading trade association for medical technology companies in the United Kingdom, are calling for reciprocal “zero for zero” tariffs between the two countries and greater regulatory convergence, noting the …
Hundred Health Acquires BellSant to Supercharge AI-Driven Longevity Platform Ahead of Full Launch: 5/6/2025 1:15:57 PM; Hundred Health, the world’s most accessible and comprehensive longevity platform, today announced an all-stock acquisition of BellSant, a health and longevity platform.
Breakthrough Study Unveils Quantum-Proof Cybersecurity for Telehealth: 5/6/2025 8:00:00 AM; A pioneering study published in Blockchain in Healthcare Today (BHTY) unveils a revolutionary cybersecurity framework designed to safeguard telehealth systems from the looming threat of quantum computing.
Johnson & Johnson’s New “Oncology Care Index” Highlights the Growing Divide Between Cancer Innovation and Implementation in Clinical Practice: 5/5/2025 10:03:20 AM; 73% of surveyed HCPs say there’s a gap between the availability of new, cutting-edge treatments and their successful implementation in clinical practice; 3 in 4 oncologists find the pace of new treatment development overwhelming Insights will boost Johnson & Johnson’s strong approach to supporting oncologists with the resources and opportunities needed to enhance patient …
Promenade Murrieta Dental Announced Computer Guided Dental Implants: 5/5/2025 6:00:00 AM; Dental implant surgery has gotten much better with new technology. Promenade Murrieta Dental now offers computer-guided dental solutions. This makes the treatment more precise and improves results.
New Edition of “Leading Ophthalmology Textbook: Manual for Eye Examination and Diagnosis” (Eleventh Edition) by Mark W. Leitman, M.D: 5/4/2025 3:05:03 PM; The much awaited eleventh edition of Mark W. Leitman, M.D.’s “Manual for Eye Examination and Diagnosis” is now accessible. This revised edition, which is still regarded as the best beginning clinical book in ophthalmology, is a vital resource for students and medical professionals around.
Restoring balance: Traditional Medicine at the World Health Summit Regional Meeting 2025: 5/2/2025 10:44:58 AM; The next World Health Organization (WHO) Traditional Medicine Global Summit, 2–4 December 2025, was unveiled during a keynote plenary session at the World Health Summit Regional Meeting 2025 in New Delhi, India, on 25 April.
Stately Bio Raises $12M Seed to Develop Next Generation Regenerative Medicines with ML-Powered Cellular Imaging Platform: 5/2/2025 10:32:13 AM; Stately Bio, a startup developing cell therapies using an ML-powered live-cell imaging platform, today announced $12 million in seed funding led by AIX Ventures, with participation from Dimension Capital, Foothill Ventures, Village Global, Caffeinated Capital, Mitsui Global Investment, BoxOne Ventures, Axial VC, Jeff Dean (Chief Scientist at Google DeepMind), Jeremy …
Can exercise and rehab services be integrated into breast cancer care?: 4/30/2025 9:13:49 AM; A recent randomized controlled trial reveals the potential of a program designed to connect patients who have breast cancer to needed exercise and rehabilitation services starting at diagnosis and throughout care.
Risk-factor Changes Could Prevent the Majority of Sudden Cardiac Arrests: 4/29/2025 1:12:29 PM; A new study identifying 56 non-clinical risk factors associated with sudden cardiac arrest (SCA), spanning lifestyle, physical measures, psychosocial factors, socioeconomic status, and the local environment, offers compelling evidence that improving these unfavorable profiles could prevent up to 63% of SCA cases.